Emmett Cuningham

EverythingALS is a non-profit organization that operates under the Peter Cohen Foundation. The private company is located in the US and has subsidiaries in the United States. Since 2020, the organization has been dedicated to advancing research, fostering innovation, and offering support for individuals and families affected by ALS. EverythingALS collaborates with a consortium of 12 pharmaceutical companies, sharing research findings and insights through its unique citizen-driven research with an open innovation model.

EverythingALS is a non-profit organization that operates under the Peter Cohen Foundation. The private company is located in the US and has subsidiaries in the United States. Since 2020, the organization has been dedicated to advancing research, fostering innovation, and offering support for individuals and families affected by ALS. EverythingALS collaborates with a consortium of 12 pharmaceutical companies, sharing research findings and insights through its unique citizen-driven research with an open innovation model.

EverythingALS is a non-profit organization that operates under the Peter Cohen Foundation. The private company is located in the US and has subsidiaries in the United States. Since 2020, the organization has been dedicated to advancing research, fostering innovation, and offering support for individuals and families affected by ALS. EverythingALS collaborates with a consortium of 12 pharmaceutical companies, sharing research findings and insights through its unique citizen-driven research with an open innovation model.

EverythingALS is a non-profit organization that operates under the Peter Cohen Foundation. The private company is located in the US and has subsidiaries in the United States. Since 2020, the organization has been dedicated to advancing research, fostering innovation, and offering support for individuals and families affected by ALS. EverythingALS collaborates with a consortium of 12 pharmaceutical companies, sharing research findings and insights through its unique citizen-driven research with an open innovation model.